March 25, 2017

Huntsman Cancer Institute, 6th Floor George S. and Dolores Dore Eccles Auditorium. View driving directions.

This conference is provided free of charge to attendees, but registration is required. Register Now


This one-day conference brings together basic researchers and clinicians with an interest in immunotherapies as promising approaches
for patients with different types of cancer. The conference will provide an update on the most recent developments in the field of cancer immunotherapy and it will facilitate collaborative efforts between basic tumor immunologists and oncologists/hematologists using novel immunotherapeutic approaches to the benefit of their patients. This conference will help us to identify the most promising immunotherapies for our patients leading to improved outcomes and maybe even cures.

Target Audience

This conference is for anyone treating patients with cancer such as medical oncologists, hematologists, surgical oncologists, radiation oncologists, primary
 care physicians, pharmacists, physician assistants, advanced practice nurses, and nurses. It is also for basic researchers interested in the role of the immune environment in cancer development and progression, the relevance of cancer immunosurveillance, tumor-specific immune responses, and the design of novel cancer immunotherapies.

Educational Objective

This conference encourages a team-oriented approach to the treatment and care of cancer patients using novel immunotherapies. It is designed to help medical professionals understand the science behind the immunotherapeutic treatments they are administering to their patients. Finally, the conference will provide and overview on the most recent developments in the fields of tumor immunology and cancer immunotherapy.

CME logo

The University of Utah School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Utah School of Medicine designates this live activity for a maximum of 6.5 PRA Caregory 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

University of Utah Health Sciences Center is an approved provider of continuing nursing education by the Western Multi-State Division, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Arizona, Colorado, Idaho, and Utah Nurses Associations are members of the Western Multi-State Division of the American Nurses Association.

Conference Chairs

Djordje Atanackovic, MD
Director, Multiple Myeloma Program & Cancer Immunotherapy
Huntsman Cancer Institute / University of Utah


Tim Luetkens, MD
Ryan O’Connell, PhD

Please contact Jeff Kenney at or 801-585-3599 if you have questions or need additional information.